SBIR/STTR Research Award

SBIR PHASE II TOPIC 294:SITE-SPECIFIC ANTIBODIES FOR GLCNACYLATED PROTEINS IN CANCER; HHSN261201300058C; POP: 9/13/13-09/12/16; CAN: 8478363 IGF::OT::IGF OTHER FUNCTIONS

Award identifier 23c3bd304935d73810093c7e1d0e8644f5147847ced30ee983dbc8d34aa33d6bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$10,338

Program and phase

SBIR · Phase II

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DETROIT R & D, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
N7KSKX4HJA58
Solicitation number
Not reported
Topic code
NCI

Research abstract

O GlcNAcylation of proteins plays a critical role in cell cycle regulationapoptosis and signal transductionModification of O GlcNAcylation of proteins by O GlcNAc transferase is reversible by the activity of O GlcNAcaseAddition and removal of O GlcNAc moiety to serine or threonine regulate the function of proteins directly or via decreased phosphorylationO GlcNAcylation of c myc proteins induces ubiquitin dependent c myc degradationGlcNAcylation of pprevents pdegradation and stabilizes pproteinswhich are beneficial in cancer cells by arresting cell growth and inducing apoptosis in response to DNA damageTo elucidate functions of O GlcNAcylation of the proteins it is necessary to develop site specific antibodies for O GlcNAcylated proteinsFew site specific antibodies have been successfully produced so farA lack of site specific O GlcNAcylated Abs prevents facile detection and quantitation of the site to elucidate the function of O GlcNAcylated molecules in physiology and diseaseAvailability of O GlcNAcylation site specific antibodies will facilitate mechanistic studies on O GlcNAcylationand phosphorylation dependent signal transduction pathway in cancerwhich will result in development of O GlcNAcylation inducing anti cancer drugs

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

18 SBIR/STTR records share this UEI (1998–2019). Reported award amounts total $5,013,748. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.